Siv Schalin appointed to the board of directors of the Algol Group

MBA Siv Schalin (53) has been appointed a member of the Board of Directors of the Algol Group as of 1 September 2015. Schalin has served as President of the Docrates Cancer Center since 2012, before which she held global management positions with companies including GE Healthcare (formerly Instrumentarium).

She is a Member of the Board of the Finnish Association of Private Health Care Service Companies, a Member of the Council of Representatives of the Hanken Foundation, and Member of the Supervisory Board of Arcada University of Applied Sciences. She also served as a Member of the Board of Outokumpu Oyj from 2011 to 2015.

Siv Schalin has considerable experience in change management, as well as diverse and broad international experience in the fields of healthcare and health technology in particular. The majority of the board of Algol has for a long time comprised members who are independent of the company and its shareholders.

We wish Siv Schalin a warm welcome to our team.

Martin Granholm
Chairman of the Board

Further information: Algol Corporate Communications, Communications Manager Heli Järvenpää,, +358 50 590 8361